Nucleic Acids Research, 1985, Vol. 13, No. 15 5545-5561
© 1985
Articles |
Fate of exogenous recombinant plasmids introduced into mouse and human cells
Istituto di Genetica Biochimica ed Evoluzionistica del C.N.R. Via Abbiategrasso, 207-27100 Pavia 1Dipartmentimento di Genetica e Microbiologia, Universitá di Pavia Via S.Epifanio, 14-27100 Pavia, Italy
*To Whom correspondence should be addressed
Received April 22, 1985. Revised June 28, 1985. Accepted July 10, 1985.
We have constructed a number of plasmids selectable in both E. coli and mouse or human cells. Human DNA sequences were inserted and the recombinant plasmids were used to transfect either mouse or human cells by the Ca-phosphate precipitation technique. We have observed that: (i) competent cells uptake large amounts of plasmid DNA; (ii) input plasmids persist in trasformed mammalian cells as free unreplicating circular molecules for up to 20 generations; such persistence does not depend on the presence of selective markers; (iii) plasmids incorporated into mouse L-cells undergo widespread rearrangements (in the absence of replication) entailing mostly deletions of both human and bacterial sequences which yield smaller products; the latter appear to be more stable in a subsequent transformation cycle. Surprisingly such rearrangements are almost totally absent in transformed human KB-cells. This property of human KB-cells mayprove useful for the development of a vector apt at cloning and expressing human DNA sequences. Unlike what has been observed in yeast, no "autonomously replicating sequence" can be detected in mammalian cells by randomly cloning human DNA sequences into a selectable plasmid and screening for an increased transformation efficiency.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Paixao, I. N. Colaluca, M. Cubells, F. A. Peverali, A. Destro, S. Giadrossi, M. Giacca, A. Falaschi, S. Riva, and G. Biamonti Modular Structure of the Human Lamin B2 Replicator Mol. Cell. Biol., April 1, 2004; 24(7): 2958 - 2967. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chen, E. L. Greene, G. Collinsworth, J. S. Grewal, O. Houghton, H. Zeng, M. Garnovskaya, R. V. Paul, and J. R. Raymond Enrichment of transiently transfected mesangial cells by cell sorting after cotransfection with GFP Am J Physiol Renal Physiol, May 1, 1999; 276(5): F777 - F785. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Cooper, M. Lippa, J. M. Payne, G. Hatzivassiliou, E. Reifenberg, B. Fayazi, J. C. Perales, L. J. Morrison, D. Templeton, R. L. Piekarz, et al. Safety-modified episomal vectors for human gene therapy PNAS, June 10, 1997; 94(12): 6450 - 6455. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tapscott, A. Lassar, R. Davis, and H Weintraub 5-bromo-2'-deoxyuridine blocks myogenesis by extinguishing expression of MyoD1 Science, August 4, 1989; 245(4917): 532 - 536. [Abstract] [PDF] |
||||



